Quince Therapeutics, Inc. (QNCX) : 1.0000-0.0800 (-7.41%)
Jan 30 (Reuters) - Quince Therapeutics Inc : * QUINCE THERAPEUTICS - ON JANUARY 24, BOARD OF COMPANY APPROVED COST REDUCTION PROGRAM TO ALIGN OPERATIONS WITH CHANGES IN CORPORATE STRATEGY * QUINCE THERAPEUTICS - UNDER PLAN, COMPANY IS REDUCING HEADCOUNT BY APPROXIMATELY 47% THROUGH A REDUCTION IN ITS WORKFORCE * QUINCE THERAPEUTICS - REDUCTION IN FORCE WILL BEGIN IN FEBRUARY 2023 AND WILL BE COMPLETED BY APRIL 2023 * QUINCE THERAPEUTICS - AS A RESULT, EXPECTS TO REALIZE ESTIMATED ANNUALIZED OPERATING EXPENSE SAVINGS OF ABOUT $9.5 MILLION IN YEAR ENDING DEC 31, 2023 * QUINCE THERAPEUTICS - REDUCTION IN FORCE WILL BEGIN IN FEBRUARY 2023 AND WILL BE COMPLETED BY APRIL 2023 * QUINCE THERAPEUTICS - EXPECTS TO REALIZE ESTIMATED ANNUALIZED OPERATING EXPENSE SAVINGS OF APPROXIMATELY $9.5 MILLION IN YEAR ENDING DECEMBER 31, 2023 * QUINCE THERAPEUTICS - IN CONNECTION WITH PLAN, COMPANY ESTIMATES THAT IT WILL INCUR EXPENSES OF APPROXIMATELY $0.6 MILLION TO $0.8 MILLION
BRIEF-Quince Therapeutics Provides Pipeline Update And Business Outlook For 2023
Jan 30 (Reuters) - Quince Therapeutics Inc : * QUINCE THERAPEUTICS PROVIDES PIPELINE UPDATE AND BUSINESS OUTLOOK FOR 2023 * QUINCE THERAPEUTICS PROVIDES PIPELINE UPDATE AND BUSINESS OUTLOOK FOR 2023 * QUINCE THERAPEUTICS - STRONG CASH POSITION OF APPROXIMATELY $94 MILLION IN CASH, EQUIVALENTS, AND MARKETABLE SECURITIES AS OF DECEMBER 31, 2022 and Potential for Quince to receive up to $150 million in regulatory and commercial milestones payments on a product-by-product basis, subject to conditions in the agreement https://finance.yahoo.com/news/quince-therapeutics-completes-sale-legacy-130000851.html * QUINCE THERAPEUTICS - CASH RUNWAY TO SUPPORT PIPELINE EXPANSION THROUGH IN-LICENSING AND ACQUISITION INTO AT LEAST 2028
Total Cash (mrq) 94.34M Total Cash Per Share (mrq) 2.61 Total Debt (mrq) 420k Shares Outstanding 36.13M Float 27.6M
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.